Search

US biotech company Intralytix was just awarded a multimillion dollar grant from NIAID to perform a phase 1/2a clinicial trial to assess safety and efficacy of phage therapy against Shigella.

Vitalis Phage Therapy In these difficult times of pandemic lockdowns and quarantine, we bring you a series of discussions called "All About Phage Therapy". For the first discussion, senior microbiologist Prof. Sanjay Chhibber from Panjab Un

Phage Directory Last week, we sent an urgent alert for phages on behalf of a patient in Finland with ESBL E. coli. The phage hunt was initiated by Mikael Skurnik and his lab at the University of Helsinki (read a nice profile on the Skurnik

Steffanie Strathdee, IPATH, UCSD Do you live on a farm? IPATH is finally re-opening after our lab was swamped by COVID19. We're looking for volunteers to send samples from animal farms for phage hunts. Email IPATH@ucsd.edu for instructions

A new phage-based skincare product has been released! Wild Resilience Active Phage Serum, made by California biotech company Ellis Day Skin Science, contains a blend of two phages (called 'Cutiphage'). This is the company's first product. R

A new phage-based skincare product has been released! Wild Resilience Active Phage Serum, made by California biotech company Ellis Day Skin Science, contains a blend of two phages (called 'Cutiphage'). This is the company's first product. R

Steffanie Strathdee, IPATH, UCSD Do you live on a farm? IPATH is finally re-opening after our lab was swamped by COVID19. We're looking for volunteers to send samples from animal farms for phage hunts. Email IPATH@ucsd.edu for instructions

Phage Directory Last week, we sent an urgent alert for phages on behalf of a patient in Finland with ESBL E. coli. The phage hunt was initiated by Mikael Skurnik and his lab at the University of Helsinki (read a nice profile on the Skurnik

We are urgently seeking Escherichia coli phages for a patient suffering from recurrent ESBL E. coli sepsis in Finland.​ Ways to help at this stage: - By receiving the strain and testing your phages - By receiving the strain and using it t

We are urgently seeking Escherichia coli phages for a patient suffering from recurrent ESBL E. coli sepsis in Finland.​ Ways to help at this stage: - By receiving the strain and testing your phages - By receiving the strain and using it t

Franck Bouchart (Univ. Polytechnique Hauts-de-France) and colleagues published an interdisciplinary paper in Materials Science and Engineering: C showing the potential of 3D-printed calcium phosphate-based ceramics filled with phage cocktai

IPATH's quarterly newsletter is out (subscribe here); in it they discuss how an IPATH phage lab, the Pride Lab, is now doing COVID testing. They interview IPATH physician Saima Aslam about phage therapy, COVID, and life. They've also got li

IPATH's quarterly newsletter is out (subscribe here); in it they discuss how an IPATH phage lab, the Pride Lab, is now doing COVID testing. They interview IPATH physician Saima Aslam about phage therapy, COVID, and life. They've also got li

Franck Bouchart (Univ. Polytechnique Hauts-de-France) and colleagues published an interdisciplinary paper in Materials Science and Engineering: C showing the potential of 3D-printed calcium phosphate-based ceramics filled with phage cocktai

A couple of phage therapy podcasts for you this week: one with John Haverty, who received phages from Adaptive Phage Therapeutics to prevent amputation of his leg in 2019. Another with Alexander Belcredi, CEO of PhagoMed.

A couple of phage therapy podcasts for you this week: one with John Haverty, who received phages from Adaptive Phage Therapeutics to prevent amputation of his leg in 2019. Another with Alexander Belcredi, CEO of PhagoMed.

Gabriel Magno de Freitas Almeida and Lotta-Riina Sundberg (University of Jyvaskyla, Finland) have published a historical review in The Lancet Infectious Diseases that dives into the forgotten history of phage therapy in Brazil. They show th

Gabriel Magno de Freitas Almeida and Lotta-Riina Sundberg (University of Jyvaskyla, Finland) have published a historical review in The Lancet Infectious Diseases that dives into the forgotten history of phage therapy in Brazil. They show th

The Cystic Fibrosis Foundation announced they will provide up to $5M to support Armata Pharmaceuticals in conducting a Phase 1b/2 clinical trial to test the safety and tolerability of phage therapy in Pseudomonas aeruginosa infections in pe

The Cystic Fibrosis Foundation announced they will provide up to $5M to support Armata Pharmaceuticals in conducting a Phase 1b/2 clinical trial to test the safety and tolerability of phage therapy in Pseudomonas aeruginosa infections in pe